Clinical Trial: A Phase III Clinical Trial to Evaluate the Efficacy and Safety of Octreotide Long-acting Injection in Patients With Acromegaly

U.S., June 4 -- ClinicalTrials.gov registry received information related to the study (NCT07623824) titled 'A Phase III Clinical Trial to Evaluate the Efficacy and Safety of Octreotide Long-acting Injection in Patients With Acromegaly' on May 29.

Brief Summary: he purpose of this study is to evaluate the efficacy and safety of SYHX2008 injection in in patients with acromegaly.

Study Start Date: May 31

Study Type: INTERVENTIONAL

Condition: Diagnosed With Acromegaly, Currently in the Active Stage of the Disease

Intervention: DRUG: SYHX2008

The patients will accept SYHX2008 injection by subcutaneous administration.A treatment period of 28 weeks.

DRUG: Sandostatin LAR(R)

The patients will accept Sandostatin LAR@ by intra-muscular admi...